+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pediatric Medicines Market 2020-2024 - Product Image

Global Pediatric Medicines Market 2020-2024

  • ID: 5011345
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
Global Pediatric Medicines Market 2020-2024

The publisher has been monitoring the pediatric medicines market and it is poised to grow by $ 27.71 bn during 2020-2024 progressing at a CAGR of 5% during the forecast period. The reports on the pediatric medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven formulatory advancement, high pediatric population, and rapid environmental deterioration resulting in several allergic conditions. In addition, formulatory advancement is anticipated to boost the growth of the market as well.

The pediatric medicines market analysis include type segments and geographic segments.

The pediatric medicines market is segmented as below:

By Type
  • Respiratory diseases
  • Infectious diseases
  • Gastrointestinal diseases
  • CNS diseases
  • Oncological diseases
  • Others
By Geographic Landscape
  • Asia
  • Europe
  • North America
  • ROW
This study identifies inorganic growth strategies as one of the prime reasons driving the pediatric medicines market growth during the next few years. Government initiatives, and oral soluble films will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The pediatric medicines market covers the following areas:
  • Pediatric Medicines Market sizing
  • Pediatric Medicines Market forecast
  • Pediatric Medicines Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pediatric medicines market vendors that include AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd.. Also, the pediatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Other 1
  • Market segments
  • Comparison by Other1
  • Enteral - Market size and forecast 2019-2024
  • Parenteral - Market size and forecast 2019-2024
  • Topical - Market size and forecast 2019-2024
  • Market opportunity by Other1
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Parent market
9. Market characteristics
10. Offerings of vendors included in the market definition
11. Market segments
12. Global - Market size and forecast 2019 - 2024 ($ billion)
13. Global market: Year-over-year growth 2019 - 2024 (%)
14. Five forces analysis 2019 & 2024
15. Bargaining power of buyers
16. Bargaining power of suppliers
17. Threat of new entrants
18. Threat of substitutes
19. Threat of rivalry
20. Market condition - Five forces 2019
21. Other1 - Market share 2019-2024 (%)
22. Comparison by Other1
23. Enteral - Market size and forecast 2019-2024 ($ billion)
24. Enteral - Year-over-year growth 2019-2024 (%)
25. Parenteral - Market size and forecast 2019-2024 ($ billion)
26. Parenteral - Year-over-year growth 2019-2024 (%)
27. Topical - Market size and forecast 2019-2024 ($ billion)
28. Topical - Year-over-year growth 2019-2024 (%)
29. Market opportunity by Other1
30. Customer landscape
31. Market share by geography 2019-2024 (%)
32. Geographic comparison
33. North America - Market size and forecast 2019-2024 ($ billion)
34. North America - Year-over-year growth 2019-2024 (%)
35. Europe - Market size and forecast 2019-2024 ($ billion)
36. Europe - Year-over-year growth 2019-2024 (%)
37. Asia - Market size and forecast 2019-2024 ($ billion)
38. Asia - Year-over-year growth 2019-2024 (%)
39. ROW - Market size and forecast 2019-2024 ($ billion)
40. ROW - Year-over-year growth 2019-2024 (%)
41. Key leading countries
42. Market opportunity by geography ($ billion)
43. Impact of drivers and challenges
44. Vendor landscape
45. Landscape disruption
46. Industry risks
47. Vendors covered
48. Market positioning of vendors
49. AbbVie Inc. - Overview
50. AbbVie Inc. - Business segments
51. AbbVie Inc. - Key offerings
52. AbbVie Inc. - Key customers
53. AbbVie Inc. - Segment focus
54. Bayer AG - Overview
55. Bayer AG - Business segments
56. Bayer AG - Key offerings
57. Bayer AG - Key customers
58. Bayer AG - Segment focus
59. F. Hoffmann-La Roche Ltd. - Overview
60. F. Hoffmann-La Roche Ltd. - Business segments
61. F. Hoffmann-La Roche Ltd. - Key offerings
62. F. Hoffmann-La Roche Ltd. - Key customers
63. F. Hoffmann-La Roche Ltd. - Segment focus
64. GlaxoSmithKline Plc - Overview
65. GlaxoSmithKline Plc - Business segments
66. GlaxoSmithKline Plc - Key offerings
67. GlaxoSmithKline Plc - Key customers
68. GlaxoSmithKline Plc - Segment focus
69. Johnson & Johnson - Overview
70. Johnson & Johnson - Business segments
71. Johnson & Johnson - Key offerings
72. Johnson & Johnson - Key customers
73. Johnson & Johnson - Segment focus
74. Merck & Co. Inc. - Overview
75. Merck & Co. Inc. - Product and service
76. Merck & Co. Inc. - Key offerings
77. Merck & Co. Inc. - Key customers
78. Merck & Co. Inc. - Segment focus
79. Novartis AG - Overview
80. Novartis AG - Business segments
81. Novartis AG - Key offerings
82. Novartis AG - Key customers
83. Novartis AG - Segment focus
84. Pfizer Inc. - Overview
85. Pfizer Inc. - Business segments
86. Pfizer Inc. - Key offerings
87. Pfizer Inc. - Key customers
88. Pfizer Inc. - Segment focus
89. Sanofi - Overview
90. Sanofi - Business segments
91. Sanofi - Key offerings
92. Sanofi - Key customers
93. Sanofi - Segment focus
94. Takeda Pharmaceutical Co. Ltd. - Overview
95. Takeda Pharmaceutical Co. Ltd. - Product and service
96. Takeda Pharmaceutical Co. Ltd. - Key offerings
97. Takeda Pharmaceutical Co. Ltd. - Key customers
98. Takeda Pharmaceutical Co. Ltd. - Segment focus
99. Currency conversion rates for US$
100. Research Methodology
101. Validation techniques employed for market sizing
102Information sources
103. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global pediatric medicines market: AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said:"The latest trend gaining momentum in the market is the inorganic growth strategies."

According to the report, one of the major drivers for this market is the formulatory advancement.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll